| 10008647 |
11α-hydroxy Testosterone
|
|
3066-12-4 |
>97%
|
|
|
2006-05-11
|
2.622099447514
|
11-hydroxy-testosterone
|
|
spi-bio spibio metabolites metabolism CYP450 CYP-450-3A CYP-3A CYP3A cytochromes M02007 endocrinology 11-hydroxytestosterone |
2.622099447514
|
| 10004303 |
11β-Hydroxysteroid Dehydrogenase (Type 1) Polyclonal Antibody
|
|
- |
>98%
|
|
|
2004-08-12
|
16.645345303867
|
11-hydroxysteroid-dehydrogenase-type-1-polyclonal-antibody
|
11β-HSD1; Corticosteroid 11β-Dehydrogenase Isozyme 1
|
antibodies western blots blotting 11.beta.-OH-steroid dehydrogenases steroids 11beta-OH-steroid 11b-hydroxysteroid antisera antiserum WB 11b-HSD 11beta-HSD 11.beta.-HSD 11b HSD endocrinology immunoblotting IHC immunohistochemistry |
16.645345303867
|
| 10004549 |
11β-Hydroxysteroid Dehydrogenase (Type 2) Polyclonal Antibody
|
|
- |
|
|
|
2005-10-05
|
6.599152854512
|
11-hydroxysteroid-dehydrogenase-type-2-polyclonal-antibody
|
Corticosteroid 11β-Dehydrogenase Isozyme 2; 11β-HSD2
|
proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry corticosteroids regulations sodium homeostasis pathophysiology hypertension converts converting cortisol inactive cortisone mutations genes encoding induction hypertension hypokalemia syndromes mineralcorticoid excess mRNA expressed placenta target tissues kidneys mouse murine tissue-specific developmentally regulated glucocorticoid-medicated maturation 11b-HSD 11beta-HSD 11.beta.-HSD 11b HSD 11b-hydroxysteroid 11beta-hydroxysteroid endocrinology immunoblotting |
6.599152854512
|
| 10008599 |
(±)14(15)-EET Ethanolamide
|
|
- |
≥95%
|
|
|
2006-08-07
|
14.656841620625
|
-14-15-eet-ethanolamide
|
(±)14(15)-EpETrE Ethanolamide; (±)14(15)-Epoxy Eicosatrienoyl Ethanolamide
|
CYP450 cytochrome P450 metabolites AEA arachidonoyl ethanolamides anandamide lipids neurotransmitter cannibinergic cannabinoid CB1 CB2 receptors enzymatic metabolism FAAH fatty acid amide hydrolases endocannabinoid neurochemistry anxiety depression neuroscience 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cbs synthetic cannabinoids |
14.656841620625
|
| 18570 |
15-deoxy-Δ12,14-Prostaglandin J2
|
|
87893-55-8 |
≥95%
|
|
|
|
157.498670963781
|
15-deoxy-12-14-prostaglandin-j2
|
15-deoxy-Δ12,14-PGJ2
|
PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2
atherosclerosis |
157.498670963781
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
26.555457335788
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
26.555457335788
|
| 10007235 |
15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard
|
|
87893-55-8 |
≥97%
|
|
|
2009-01-16
|
51.545994475138
|
15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard
|
15-deoxy-Δ12,14-PGJ2
|
PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards |
51.545994475138
|
| 10007950 |
15-hydroxy Prostaglandin Dehydrogenase (human recombinant)
|
|
- |
≥95% by SDS-PAGE
|
|
|
2007-01-16
|
54.825201262825
|
15-hydroxy-prostaglandin-dehydrogenase-human-recombinant
|
15-hydroxy PGDH
|
15-OH PGDH 15-PGDH proteins binding enzymes dehydrogenases recombinant tumors suppressors colon thyroid breast cells |
54.825201262825
|
| 60712 |
15-Lipoxygenase (soybean P1)
|
|
- |
|
|
|
|
27.347004297115
|
15-lipoxygenase-soybean-p1
|
15-LO; 15-LOX
|
15-LOs soybean 15-lipoxygenases P1 enzymes |
27.347004297115
|
| 60700 |
15-Lipoxygenase (soybean P1) - Purified
|
|
- |
>98%
|
|
|
|
24.737704671019
|
15-lipoxygenase-soybean-p1-purified
|
15-LO; 15-LOX
|
15-LOs enzymes soybean 15-lipoxygenases P1 |
24.737704671019
|
| 10008518 |
4-hydroxy Diclofenac
|
|
64118-84-9 |
≥97%
|
|
|
2006-05-11
|
63.848425414364
|
4-hydroxy-diclofenac
|
|
spi-bio spibio metabolites metabolism CYP450 CYP-450-2C9 CYP-2C9 CYP2C9 cytochromes M02004 |
63.848425414364
|
| 10008520 |
4-hydroxy Tolbutamide
|
|
5719-85-7 |
>97%
|
|
|
2006-05-11
|
34.732403314917
|
4-hydroxy-tolbutamide
|
|
spi-bio spibio metabolites metabolism CYP450 CYP-450-2C9 CYP-2C9 CYP2C9 cytochromes M02009 |
34.732403314917
|
| 10010375 |
5-Iodotubercidin
|
|
24386-93-4 |
≥95%
|
|
|
2008-01-24
|
40.749410681400
|
5-iodotubercidin
|
Itu; NSC 113939
|
adensosine glycogen hepatocytes phosphorylase .alpha. glycogen synthase .alpha. kinases protein kinase A casein kinases II casein kinases I protein kinase C phosphorylase kinases EFK2 MAPK1 cell proliferations fatty acid oxidations lipogenesis acetyl-CoA carboxylase |
40.749410681400
|
| 10009029 |
6-hydroxy Chlorzoxazone
|
|
1750-45-4 |
≥97%
|
|
|
2006-07-12
|
3.712707182320
|
6-hydroxy-chlorzoxazone
|
NSC 24955
|
SPI-BIO SPIBIO substrates CYP2C8 CYP-2C8 CYP 2C8 cytochromes metabolites M02003 |
3.712707182320
|
| 19027 |
6α-hydroxy Paclitaxel
|
|
153212-75-0 |
≥97%
|
|
|
2009-09-23
|
14.431049723756
|
6-hydroxy-paclitaxel
|
|
10009027 substrates CYP450 CYP-450-2E1 CYP-2E1 CYP2E1 cytochromes metabolites M02006 |
14.431049723756
|
| 10008519 |
6β-hydroxy Testosterone
|
|
62-99-7 |
≥97%
|
|
|
2006-05-11
|
2.622099447514
|
6-hydroxy-testosterone
|
4-Androsten-6β,17β-diol-3-one; 6β, 17β,-Dihydroxyandrost-4-en-3-one
|
metabolites metabolism CYP450 CYP-450-3A CYP-3A CYP3A cytochromes M02008 endocrinology CYP3A4 CYP3A5 P450 glucocorticoids xenobiotics steroids hormones testosterone |
2.622099447514
|
| 10007417 |
9-Thiastearic Acid
|
|
106689-24-1 |
>98%
|
|
|
2005-07-20
|
0.963977900552
|
9-thiastearic-acid
|
|
heteroatom-substituted fatty acids modulates extensions desaturating distribution phospholipids pools radiolabeled stearate oleate rat hepatocytes hepatoma cellshypolipidemic effects anti-obesity therapeutics |
0.963977900552
|
| 700600 |
Aconitase Fluorometric Assay Kit
New |
|
- |
|
|
|
2011-09-14
|
201.943127440147
|
aconitase-fluorometric-assay-kit
|
|
kits assays measures measurements [Fe4S4]2+ iron-sulfur proteins cluster catalyzes stereo-specific isomerization citrate isocitrate cis-aconitate tricarboxylic acids Krebs cycles glyoxylate citric substrates eukaryotes enzymes cytosolic cAcn mitochondrial mAcn genes bacteria prokaryotes aconitase A B AcnA AcnB enzymatic oxidants superoxides hydrogen peroxides H2O2 cells pro-oxidants oxidative damage aging in vitro reactivation ferrous ions cardiac ischemia/reperfusion events fluorescence-based tissues homogenates lysates coupled reactions a-ketoglutarate alpha-ketoglutarate .alpha.-ketoglutarate α-ketoglutarate quantifying isomerized decarboxylation dehydrogenases concomitant formations NADPH NADP+ fluorescent nicotinamides adenines dinucleotides phosphates |
201.943127440147
|
| 10006409 |
Adipose Triglyceride Lipase Polyclonal Antibody
|
|
- |
|
|
|
2005-11-23
|
16.582722967639
|
adipose-triglyceride-lipase-polyclonal-antibody
|
Phospholipase A2ζ; Desnutrin; ATGL
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting |
16.582722967639
|
| 10010241 |
AICAR
|
|
2627-69-2 |
>98%
|
|
|
2008-02-25
|
141.414828729282
|
aicar
|
NSC 105823; Acadesine; AICA Riboside
|
AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide |
141.414828729282
|
| 700260 |
Alanine Transaminase Activity Assay Kit
|
|
- |
|
|
|
2010-01-06
|
224.304605936926
|
alanine-transaminase-activity-assay-kit
|
ALT Activity Assay Kit; ALAT Activity Assay Kit; Alanine Aminotransferase Activity Assay Kit; sGPT Activity Assay Kit; Serum Pyruvic Transaminase Activity Assay Kit
|
alanines aminotransferases homodimeric cytoplasmic pyridoxal phosphate-enzymes cells cellular nitrogen metabolism amino acids transamination a-ketoglutarates alpha-ketoglutarates α-ketoglutarates pyruvates glutamates tissues livers kidneys heart brains glucose neuronal glutamates alanine-aminotransferases reactions diseases injury diabetes cirrhosis fatty hepatitis carcinomas mononucleosis muscular dystrophy cardiovascular serums plasmas samples lysates NADH oxidations lactate dehydrogenases LDH NAD+ assays kits measures measurements |
224.304605936926
|
| 13452 |
AM3102
Exclusive |
|
213182-22-0 |
≥98%
|
|
✓ |
2009-08-11
|
45.108392879067
|
am3102
|
KDS-5104
|
OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic |
45.108392879067
|
| 580170 |
ANGPTL3 (human) EIA Kit
New |
|
- |
|
|
|
2012-01-10
|
110.448067613786
|
angptl3-human-eia-kit
|
Angiopoietin-like protein 3
|
kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL6 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 livers pro-angiogenic integrins αvβ3 endothelial cells migration adhesion inhibits inhibitors inhibition catalytic lipoproteins lipases catalyzes hydrolysis triglycerides HDL high density phospholipids hypolipidemic obese ob KK/Snk mice mouse expression hyperlipidemia atherosclerosis plasma human cholesterols immunometrics sandwich serums cultures supernatants |
110.448067613786
|
| 10805 |
ANGPTL3 (human) Monoclonal Antibody (Clone Kairos-37)
|
|
- |
|
|
|
2011-05-12
|
1.458563535912
|
angptl3-human-monoclonal-antibody-clone-kairos-37
|
ANGPT5; Angiopoietin-Like Protein 3; FHBL2; Angiopoietin-5
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANG-5 |
1.458563535912
|
| 10806 |
ANGPTL3 (murine) Monoclonal Antibody (Clone Kairos3-1541)
|
|
- |
|
|
|
2011-05-12
|
0.486187845304
|
angptl3-murine-monoclonal-antibody-clone-kairos3-1541
|
Angiopoietin-5; FHBL2; Angiopoietin-Related Protein 3; ANG-5; ANGPT5; Angiopoietin-Like 3
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANG5 ANG 5 |
0.486187845304
|
| 10807 |
ANGPTL3 (murine) Monoclonal Antibody (Clone Kairos3-3741)
|
|
- |
|
|
|
2011-05-12
|
0.486187845304
|
angptl3-murine-monoclonal-antibody-clone-kairos3-3741
|
FHBL2; ANGPT5; Angiopoietin-5; Angiopoietin-Related Protein 3; ANG-5; Angiopoietin-Like 3
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANG5 ANG 5 |
0.486187845304
|
| 580190 |
ANGPTL6 (human) EIA Kit
New |
|
- |
|
|
|
2012-01-10
|
107.686974325642
|
angptl6-human-eia-kit
|
Angiopoietin-like protein 6
|
kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL3 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 hepatocytes angiogenesis arteriogenesis ERK1/2-eNOS pathways transgenic mice mouse systemic expenditure high-fat diet-induced obesity ob insulin resistance null diabetic fasting serums levels immunometric sandwich plasma cells cultures supernatants |
107.686974325642
|
| 10808 |
ANGPTL6 (human) Monoclonal Antibody (Clone Kairos-60)
|
|
- |
|
|
|
2011-06-27
|
0.486187845304
|
angptl6-human-monoclonal-antibody-clone-kairos-60
|
AGF; Angiopoietin-Related Growth Factor; Angiopoietin-Like Protein 6
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay ANGPTL-6 ANGPTL energy metabolism glucose lipids |
0.486187845304
|
| 13042 |
ApoAI Monoclonal Antibody (Clone CC3821C4)
Exclusive |
|
- |
|
|
✓ |
2008-10-15
|
23.606390423572
|
apoai-monoclonal-antibody-clone-cc3821c4
|
Apolipoprotein AI
|
antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins |
23.606390423572
|
| 700420 |
Ascorbate Assay Kit
|
|
- |
|
|
|
2010-09-01
|
196.081095601639
|
ascorbate-assay-kit
|
L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit
|
kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD |
196.081095601639
|
| 10009021 |
AVE-1625
Exclusive |
|
358970-97-5 |
>98%
|
|
✓ |
2008-04-03
|
121.810082872928
|
ave-1625
|
|
cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry |
121.810082872928
|
| 60924 |
Azelaoyl PAF
|
|
- |
>98%
|
|
|
|
63.528618784530
|
azelaoyl-paf
|
|
PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors |
63.528618784530
|
| 10006427 |
Berberine
|
|
633-65-8 |
>95%
|
|
|
2005-05-25
|
7.901885359115
|
berberine
|
Umbellatine; BBR
|
natural alkoloid hypocholesterolemic activity berberidaceaen medicine antiprotozoal antidiahreal agents reduces total cholesterol LDLR low-density lipoproteins triglycerides high fat diet LDL-receptors proteins mRNA levels hepatocytes serum atherosclerosis |
7.901885359115
|
| 11103 |
Branched Chain Amino-Acid Transferase 2 (human recombinant)
New |
|
- |
≥95%
|
|
|
2011-11-29
|
18.888888888889
|
branched-chain-amino-acid-transferase-2-human-recombinant
|
BCATm; ECA40; Placental Protein 18; PP18; BCT2; BCAT2
|
metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases enzymes amino acids cells leucine isoleucine valine endothelial nitric oxide reactive oxygen species ROS PLP mitochondrial BCATm cytosolic BCATc brain BCAAs BCAT-2 |
18.888888888889
|
| 71748 |
CAY10415
Exclusive |
|
146062-49-9 |
≥98%
|
|
✓ |
2008-07-28
|
91.943683241252
|
cay10415
|
|
thiazolidinediones TZDs PPARgamma PPARg PPAR.gamma. antidiabetic anti-diabetic insulin blood glucose resistance lipogenesis peroxisome proliferators activated receptors |
91.943683241252
|
| 10006545 |
CAY10464
Exclusive |
|
688348-37-0 |
≥98%
|
|
✓ |
2005-10-25
|
22.933107734806
|
cay10464
|
|
resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar intracellular transcription factors PAHs hydrocarbons antagonists receptors |
22.933107734806
|
| 10007875 |
CAY10499
Exclusive |
|
359714-55-9 |
>98%
|
|
✓ |
2006-07-25
|
9.754143646408
|
cay10499
|
|
obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology |
9.754143646408
|
| 10009079 |
CAY10506
Exclusive |
|
292615-75-9 |
≥98%
|
|
✓ |
2008-11-17
|
73.244309392265
|
cay10506
|
|
diabetes glucose metabolism TZDs PPARγ agonists α-lipoic acids anti-diabetic |
73.244309392265
|
| 10010032 |
CAY10570
Exclusive |
|
875014-22-5 |
>98%
|
|
✓ |
2008-06-03
|
16.145870165746
|
cay10570
|
|
FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids |
16.145870165746
|
| 13143 |
CAY10587
Exclusive |
|
1082058-99-8 |
≥98%
|
|
✓ |
2009-07-02
|
21.141132596685
|
cay10587
|
|
free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors |
21.141132596685
|
| 10012536 |
CAY10592
Exclusive |
|
685139-10-0 |
≥98%
|
|
✓ |
2009-02-26
|
39.451790055248
|
cay10592
|
|
selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn |
39.451790055248
|
| 10009796 |
CAY10602
|
|
374922-43-7 |
≥95%
|
|
|
2009-07-15
|
19.213069367710
|
cay10602
|
|
SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB |
19.213069367710
|
| 10007171 |
Cetaben
|
|
55986-43-1 |
≥98%
|
|
|
2005-11-11
|
1.833767955800
|
cetaben
|
Hexadecylamino-p-amino Benzoic Acid
|
clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology |
1.833767955800
|
| 70930 |
Chlorogenic Acid
|
|
327-97-9 |
≥95%
|
|
|
|
28.736887661141
|
chlorogenic-acid
|
NSC 407296; Heriguard; 3-O-Caffeoylquinic acid
|
antioxidants acids plants metabolism polyphenolic |
28.736887661141
|
| 10007640 |
Cholesterol Assay Kit
|
|
- |
|
|
|
2006-02-28
|
130.915453605490
|
cholesterol-assay-kit
|
|
Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis assays fluorescent fluorometric |
130.915453605490
|
| 71730 |
Ciglitazone
|
|
74772-77-3 |
≥98%
|
|
|
|
56.195560020090
|
ciglitazone
|
U-63287; ADD 3878
|
nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology |
56.195560020090
|
| 700440 |
Coenzyme A Assay Kit
|
|
- |
|
|
|
2011-01-19
|
59.023417158823
|
coenzyme-a-assay-kit
|
CoA Assay Kit
|
kits assays measures measurements coenzymes biosynthesized enzymatic pantothenate vitamin B5 cofactors acyl groups carriers carbonyl-activating TCA cycles fatty acids metabolisms acetates acetyl-CoA acetyl-coenzymes A melatonin heme rat livers diabetes fasting hypolipidemic drugs fat diets tumors plasma serum urine europium chlorides tetracyclines periodic |
59.023417158823
|
| 500360 |
Cortisol EIA Kit
|
|
- |
|
|
|
2010-04-26
|
446.115419781172
|
cortisol-eia-kit
|
|
solid plates 582121 kits assays EIAs ELISAs enzymes immunoassays glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland enzymes hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices |
446.115419781172
|
| 500370 |
Cortisol Express EIA Kit
|
|
- |
|
|
|
2010-05-20
|
223.987098132070
|
cortisol-express-eia-kit
|
Cortisol Express ELISA Kit
|
solid plates 10006791 EIAs steroids antisera hormones immunoassays reagents antiserums kits ELISAs enzymes glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices same day sameday results |
223.987098132070
|
| 700520 |
D-Lactate Assay Kit
|
|
- |
|
|
|
2011-02-23
|
74.465604276153
|
d-lactate-assay-kit
|
|
kits assays measures measurements D(-)-Lactates stereoisomers blood exogenous fermented foods yogurt sauerkraut pickles gastrointestinal tract lactobacilli bifidobacteria cytosols cells glyoxylase I II pathways methylglyoxal glutathione S-D-lactoylglutathione L-lactate L(+)-lactate pyruvates dehydrogenases LDH liver D-a-hydroxy acid D-alpha-hydroxy D-α-hydroxy mammals enzymes humans murines mitochondrial mitochondria D-lactic acidosis metabolic serum neurotoxic fermentation carbohydrates kidneys short bowel syndromes jejunoileal bypass surgery diabetes infection ischemia trauma monogastric malabsorptive nutrient sepsis plasma urine saliva intracellular extracellular cell culture samples oxidation reduction NAD+ NADH |
74.465604276153
|
| 11095 |
DL-Palmitoylcarnitine chloride
New |
|
6865-14-1 |
≥95%
|
|
|
2011-12-07
|
27.777777777778
|
dl-palmitoylcarnitine-chloride
|
NSC 628323; Palmitoyl-DL-carnitine chloride
|
carnitine acylcarnitine fatty acids oxidation mitochondria calcium tight junctions permeability cells calcium endothelial epithelial 6819-24-5 52234-80-7 68960-79-2 127719-10-2 carnitine palmitoyl intracellular extracellular oxidation energy mobilization junctions viability permeability resistance |
27.777777777778
|
| 10011296 |
(E)-Guggulsterone
|
|
39025-24-6 |
≥98%
|
|
|
2009-12-03
|
0.966850828729
|
-e-guggulsterone
|
|
anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees |
0.966850828729
|
| 10009798 |
EX-527
|
|
49843-98-3 |
≥98%
|
|
|
2009-10-23
|
26.102891344382
|
ex-527
|
|
sirtuins SIRT1 histones deacetylase HDAC energy metabolism inflammation inhibitors p53 DNA damage 848193-68-0 848193-69-1 |
26.102891344382
|
| 10009547 |
FABP1 (human recombinant)
Exclusive |
|
- |
>90%
|
|
✓ |
2007-09-04
|
9.086550030693
|
fabp1-human-recombinant
|
Liver-FABP; L-FABP; Fatty Acid Binding Protein
|
proteins metabolism cellular membranes FABP-1 FABPs fatty acids bladders carcinoma renal failure LFABP livers kidneys atherosclerosis endocrinology |
9.086550030693
|
| 10005200 |
FABP1 (rat recombinant)
|
|
- |
>95%
|
|
|
2005-07-29
|
8.036243093922
|
fabp1-rat-recombinant
|
Liver-Fatty Acid Binding Protein; Fatty Acid Binding Protein 1; Liver-FABP; L-FABP
|
protein-only proteins cytosolic fatty acids antiparallel .beta. strands barrel expression hepatoblastoma hepatocellular carcinomas tumors markers liver kidney injury fluorescence displacement assay fluorescent analogue 11-(Dansylamino)undecanoic DAUDA arachidonic oleic pocket atherosclerosis endocrinology |
8.036243093922
|
| 10009549 |
FABP4 (human recombinant)
|
|
- |
>90%
|
|
|
2007-06-15
|
30.360148746281
|
fabp4-human-recombinant
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; A-FABP; Adipocyte Fatty Acid Binding Protein; aP2
|
cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology |
30.360148746281
|
| 9001068 |
FABP4 (human recombinant) FITC conjugated
New |
|
- |
≥95%
|
|
|
2011-08-23
|
11.593022888713
|
fabp4-human-recombinant-fitc-conjugated
|
ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4
|
fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 |
11.593022888713
|
| 10010463 |
FABP4 (human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-10-23
|
5.106180939226
|
fabp4-human-recombinant-western-ready-control
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting |
5.106180939226
|
| 10010231 |
FABP4 Inhibitor/Ligand Screening Assay Kit
|
|
- |
|
|
|
2007-11-01
|
23.683769655758
|
fabp4-inhibitor-ligand-screening-assay-kit
|
aP2; Adipocyte FABP; A-FABP; Fatty Acid Binding Protein 4
|
fabps kits atherosclerosis assays fatty acid binding protein adipocytes aP2 cytosolic lipophilic ligands uptake metabolisms cellular membranes intracellular trafficking cells growth differentiation PPARg PPARgamma PPAR.gamma. peroxisomes proliferator-activated receptors agonists insulin genes deletion mice mouse murine chronic metabolic diseases diabetes atherosclerosis fluorescence fluorescent fluorometric endocrinology |
23.683769655758
|
| 10005191 |
FABP4 (mouse recombinant)
|
|
- |
>95%
|
|
|
2005-07-27
|
10.065867403314
|
fabp4-mouse-recombinant
|
Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP
|
protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology |
10.065867403314
|
| 10009676 |
FABP4 (mouse recombinant) Western Ready Control
|
|
- |
|
|
|
2007-04-30
|
4.295814917127
|
fabp4-mouse-recombinant-western-ready-control
|
ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis |
4.295814917127
|
| 10004944 |
FABP4 Polyclonal Antibody
|
|
- |
|
|
|
2004-11-05
|
12.553962115233
|
fabp4-polyclonal-antibody
|
Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP
|
atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting |
12.553962115233
|
| 10009551 |
FABP7 (human recombinant)
|
|
- |
>90%
|
|
|
2007-06-27
|
4.380059498512
|
fabp7-human-recombinant
|
B-FABP; Brain-FABP; Fatty Acid Binding Protein 7
|
cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology |
4.380059498512
|
| 10005368 |
Fenofibrate
|
|
49562-28-9 |
≥98%
|
|
|
2004-09-15
|
22.251700429711
|
fenofibrate
|
|
PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology |
22.251700429711
|
| 700310 |
Free Fatty Acid Assay Kit
|
|
- |
|
|
|
2010-09-08
|
109.454098904597
|
free-fatty-acid-assay-kit
|
FFA
|
kits assays measures measurements acids triglycerides intestines hydrolyzed glycerols enzymes pancreas pancreatic lipases intestinal liposomes capillaries lymph systems blood plasmas serums hepatocytes adipocytes muscles fibers oxidized sugars glucagon fats proteins albumin FFA skeletal skeletons hearts livers pathophysiological obesity insulin resistance type 2 II diabetes pathogenesis insulin-stimulated peripheral glucose uptake beta cells oxidative stressproinflammatory effects NFκB nuclear factors inflammation resistances metabolic urine enzymatic reactions Acyl CoA synthetase ACS acylation coenzymes oxidases ACOD hydrogen peroxides H2O2 horseradish peroxidases HRP 10-aceyl-3,7-dihydroxyphenozazine ADHP fluorescence fluorescent resorufins |
109.454098904597
|
| 11104 |
Fructose 1,6-bisphosphatase (human recombinant)
New |
|
- |
≥95%
|
|
|
2011-11-29
|
78.492511590196
|
fructose-1-6-bisphosphatase-human-recombinant
|
FDPase; FBP1; F1,6BPase
|
metabolism insulin non-insulin-dependent type 2 diabetes mellitus glucose kinases fructose 1,6-diphosphatase liver enzymes gluconeogenesis phosphofructokinase glycolysis lactate glycerol alanine NIDDM hyperglycemia |
78.492511590196
|
| 10010622 |
Genipin
|
|
6902-77-8 |
≥98%
|
|
|
2008-05-09
|
99.322569060774
|
genipin
|
(+)-Genipin
|
obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity |
99.322569060774
|
| 10990 |
Glucokinase (human liver recombinant)
New |
|
- |
≥85%
|
|
|
2011-09-08
|
46.668330263965
|
glucokinase-human-liver-recombinant
|
Human Hexokinase IV isoform 2; Hexokinase D; ATP:D-Hexose 6-Phosphotransferase GCK
|
metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases GCK ATP-dependent phosphorylation glycolytic liver tissues neurons pancreatic cells pituitary endocrine hexokinases mutations |
46.668330263965
|
| 10989 |
Glucokinase (human pancreatic recombinant)
New |
|
- |
≥90%
|
|
|
2011-09-08
|
48.557219152854
|
glucokinase-human-pancreatic-recombinant
|
Hexokinase D; ATP:D-Hexose 6-Phosphotransferase GCK; Human Hexokinase IV isoform 1
|
metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases GCK ATP-dependent phosphorylation glycolytic liver tissues neurons pancreatic cells pituitary endocrine hexokinases mutations |
48.557219152854
|
| 700300 |
Glucose-6-Phosphate Dehydrogenase Activity Assay Kit
|
|
- |
|
|
|
2011-07-28
|
88.633117496585
|
glucose-6-phosphate-dehydrogenase-activity-assay-kit
|
G6PDH Activity Assay Kit
|
kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent |
88.633117496585
|
| 10009582 |
Glucose Assay Kit
|
|
- |
|
|
|
2007-06-11
|
173.837822271914
|
glucose-assay-kit
|
|
assays kits monosaccharides simple sugars carbohydrates blood stream energy cells hyperglycemia hypoglycemia Diabetes mellitus oxidase-peroxide d-gluconolactone delta-gluconolactone .delta.-gluconolactone plasma serum urine endocrinology |
173.837822271914
|
| 600470 |
Glucose Uptake Cell-Based Assay Kit
New |
|
- |
|
|
|
2011-12-14
|
103.757944371315
|
glucose-uptake-cell-based-assay-kit
|
|
assay kits measuring measurement CBAs C6H12O6 energy metabolisms adenosines triphosphates ATP cells homeostasis intestines blood muscles liver glycogens hydrolyzed levels transporters concentrations gradients energy-dependent uptakes gut kidneys rate hormones human growth factors insulin proliferation atrophy cancers pathways aerobic glycolysis anti-cancer effects drugs discovery fluorescent analogs 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose 2-NBDG modulators cellular deoxyglucose cultured apigenin flavonoid |
103.757944371315
|
| 700720 |
Glycerol Fluorometric Assay Kit
New |
|
- |
|
|
|
2012-01-17
|
121.085717306741
|
glycerol-fluorometric-assay-kit
|
|
assays kits measures measurements flourometer fluorometry triglycerides storage fats metabolites energy metabolisms oxidations physiological pathological hydrolyzed free fatty acids FFAs blood glucose sugar gluconeogenesis lipolysis serums concentrations kinases x-linked inborn hyperglycerolemia glyceroluria fluorescence-based plasma phosphorylated glycerol-3-phosphates G-3-P adenosine-5'-diphosphates ADP oxidized phosphates oxidases dihydroxyacetones hydrogen peroxides H2O2 horseradish HRPs 1-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin |
121.085717306741
|
| 700480 |
Glycogen Assay Kit
|
|
- |
|
|
|
2011-08-02
|
78.053299606376
|
glycogen-assay-kit
|
|
kits assays measures measurements polysaccharides storage glucose animal human cells polymers alpha(1,4) .alpha.(1,4) α(1,4) linkages units backbones livers muscles glycogenesis glycolysis brains stomachs granules cytosols cycles hepatocytes source available glucose-6-phosphatases blood kidneys glial WBCs white uterus pregnancy embryo abnormal metabolisms diabetes mellitus synthesis storage diseases von Gierke's Pompe McArdle's tissues hydrolyzed hydrolysis amyloglucosidases .beta.-D-glucose beta-D-glucose β-D-glucose oxidized oxidases hydrogen peroxides H2O2 horseradish peroxidases HRP 10-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin |
78.053299606376
|
| 600450 |
Glycolysis Cell-Based Assay Kit
Exclusive New |
|
- |
|
|
✓ |
2011-08-18
|
95.030094243709
|
glycolysis-cell-based-assay-kit
|
|
CBAs assays kits measures colorimetric colorimetric-based L-lactate culture media mediums cellular metabolic pathways glucose metabolisms cells ATP adenosines triphosphates oxygen exercise erythrocytes mitochondria glucoeogenesis intracellular molecules amino acids insulin glycolytic neurons aerobic energy muscles anaerobic cancers lactate pyruvate tricarboxylic acids cycles oxidizes carbon dioxide CO2 water H2O tumor aggressiveness embryonic stem activity hypoxia-inducible transcriptional factors HIF-1 extracellular inhibition inhibits inhibitors chemotherapeutic strategies strategy metabolomic drugs discovery anticancer |
95.030094243709
|
| 10011424 |
GRP94 Monoclonal Antibody (Clone 9G10)
|
|
- |
|
|
|
2008-04-23
|
2.594843462247
|
grp94-monoclonal-antibody-clone-9g10
|
GP94; Glucose Regulated Protein 94
|
chaperones heat shock proteins immunoblots antibodies glucose stress oxidative WB IP FC western blots immunoblotting immunoprecipitation flow cytometry antiserum blotting |
2.594843462247
|
| 10006798 |
GW 0742
|
|
317318-84-6 |
≥98%
|
|
|
2007-07-25
|
20.800607734806
|
gw-0742
|
|
PPAR PPAR.beta. PPAR.delta. peroxisome proliferator activated receptor neurotoxicity agonists neuroprotection toxicity apoptosis lipids metabolism atherosclerosis endocrinology GW0742 GW-0742 |
20.800607734806
|
| 10009880 |
GW 590735
Exclusive |
|
622402-22-6 |
≥98%
|
|
✓ |
2007-06-18
|
5.925966850829
|
gw-590735
|
|
PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology |
5.925966850829
|
| 10008613 |
GW 7647
|
|
265129-71-3 |
≥98%
|
|
|
2006-08-02
|
16.717079715863
|
gw-7647
|
|
PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 |
16.717079715863
|
| 10011211 |
GW 9578
Exclusive |
|
247923-29-1 |
≥98%
|
|
✓ |
2008-05-23
|
23.362681682957
|
gw-9578
|
|
atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated |
23.362681682957
|
| 70785 |
GW 9662
|
|
22978-25-2 |
≥98%
|
|
|
|
87.012878453038
|
gw-9662
|
|
GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis |
87.012878453038
|
| 9000497 |
GW 9662-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2009-09-30
|
44.903296500920
|
gw-9662-d5
|
|
deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs |
44.903296500920
|
| 10010559 |
HA-1077 (hydrochloride)
|
|
203911-27-7 |
≥98%
|
|
|
2008-09-03
|
68.667826887661
|
ha-1077-hydrochloride
|
Eril; Fasudil; AT-877
|
protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 |
68.667826887661
|
| 10006084 |
Hesperetin
|
|
520-33-2 |
≥98%
|
|
|
2005-02-16
|
10.879016574585
|
hesperetin
|
|
hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis |
10.879016574585
|
| 10009026 |
homo-Tienilic Alcohol
|
|
236735-89-0 |
>95%
|
|
|
2006-07-12
|
8.448232044199
|
homo-tienilic-alcohol
|
|
SPI-BIO SPIBIO substrates CYP450 CYP-450-2C18 CYP-2C18 CYP2C18 cytochromes M02002 |
8.448232044199
|
| 10006371 |
Hormone Sensitive Lipase Polyclonal Antibody
|
|
- |
|
|
|
2005-06-22
|
8.847826887661
|
hormone-sensitive-lipase-polyclonal-antibody
|
HSL; LIPE
|
proteins antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry catalyses hydrolysis of tri- di- monoacylglycerols cholesterol esters mobilizes fatty acids primary source energy mammals enzyme expressed adipose tissues stearidonic steroidgenesis spermatogenesis foam cell formation atherosclerosis diabetic pathology human cDNA isoforms testis mRNA mouse murine macrophages testicular ram seminal vesicles triacylglycerols diacylglycerols atherosclerosis |
8.847826887661
|
| 500340 |
Human Serum Albumin EIA Kit
|
|
- |
|
|
|
2009-07-16
|
105.600950276243
|
human-serum-albumin-eia-kit
|
Albumin (human serum) EIA Kit; HSA ELISA Kit
|
solid plates EIAs ELISAs enzymes immunoassays kits measures measurement renal kidneys blood proteins serums osmotic pressure buffering pH hormones fatty acids transports transportation microaluminuria macroalbuminuria disease non-diabetic nephropathy cardiovascular morbidity mortality creatinine assays |
105.600950276243
|
| 10633 |
JWH 073 2-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2011-01-11
|
37.668238301845
|
jwh-073-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs JWH073 JWH-073 cannabinoids cbs synthetic JWH 73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
37.668238301845
|
| 10009324 |
LCAT Blocking Peptide
|
|
- |
|
|
|
2007-01-03
|
21.612658839778
|
lcat-blocking-peptide
|
Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol-O-Acyltransferase
|
antibodies western blotting blots signaling signalling WB controls peptides proteins cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary |
21.612658839778
|
| 10009323 |
LCAT Polyclonal Antibody
|
|
- |
|
|
|
2007-01-03
|
20.924389195825
|
lcat-polyclonal-antibody
|
Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol O-Acyltransferase
|
proteins diseases antibodies antisera antiserum WB western blots blotting cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary atherosclerosis immunoblotting |
20.924389195825
|
| 700510 |
L-Lactate Assay Kit
|
|
- |
|
|
|
2011-02-21
|
115.792285905363
|
l-lactate-assay-kit
|
|
kits assays measures measurements L(+)-lactates stereoisomers humans metabolisms pyruvates ratios redox reduction oxidation cells NAD+ NADH dehydrogenases LDH glycolysis oxygen Cori cycles livers monocarboxylates tissues skeletal cardiac muscles kidneys substrates feedback inhibition lactic acidosis exercise convulsions sepsis respiratory failure HIV cancers diabetes serum plasma blood urine saliva intracellular extracellular cell culture samples |
115.792285905363
|
| 90290 |
MEDICA 16
|
|
87272-20-6 |
>98%
|
|
|
|
15.703287292818
|
medica-16
|
|
hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis |
15.703287292818
|
| 10006356 |
Melanocortin-4 Receptor Blocking Peptide
|
|
- |
|
|
|
2005-09-08
|
8.377348066299
|
melanocortin-4-receptor-blocking-peptide
|
MC4R
|
peptides proteins antibodies signaling signalling WB western blots blotting IHC immunohistochemistry formalin-fixed paraffin-embedded tissues sections melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE |
8.377348066299
|
| 10006355 |
Melanocortin-4 Receptor Polyclonal Antibody
|
|
- |
|
|
|
2005-08-03
|
15.466270718232
|
melanocortin-4-receptor-polyclonal-antibody
|
MC4R
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting |
15.466270718232
|
| 10007188 |
Microcystin-LR
|
|
101043-37-2 |
>95%
|
|
|
2005-07-20
|
20.820000000000
|
microcystin-lr
|
Cyanoginosin-LR
|
proteins phosphatases inhibitors microcystins toxins hepatotoxic cyclics heptapeptides cyanobacteria poisonings humans livestock fresh water blue-green algae endemic PP-2A inhibits enzymes PP-1 serine/threonine nodularins okadaic acids |
20.820000000000
|
| 10813 |
Nampt Monoclonal Antibody (Clone OMNI 379)
|
|
- |
|
|
|
2011-06-27
|
4.667817679558
|
nampt-monoclonal-antibody-clone-omni-379
|
Nicotinamide Phosphoribosyltransferase; Pre-B Cell Colony Enhancing Factor 1; Visfatin; PBEF1
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay flow cytometry FC immunocytochemistry ICC immunohistochemistry IHC immunoprecipitation IP iNampt eNampt NAD+ adenine dinucleotide intracellular extracellular |
4.667817679558
|
| 579020 |
Nampt/Visfatin (human) EIA Kit
|
|
- |
|
|
|
2011-04-21
|
40.944726826274
|
nampt-visfatin-human-eia-kit
|
Nicotinamide Phophoribosyltransferase/Visfatin
|
Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues |
40.944726826274
|
| 10584 |
(−)-Neplanocin A
Exclusive |
|
72877-50-0 |
≥98%
|
|
✓ |
2011-03-25
|
55.264554064720
|
-neplanocin-a
|
|
S-adenosylhomocysteines hydrolases SAH inhibitors S-adenosylmethionines SAM methyltransferases antitumor antiviral cancer virus methylation Neplanocin A neplanocinA anti-tumor |
55.264554064720
|
| 10009661 |
N-Octadecyl-N'-propyl-sulfamide
|
|
- |
>95%
|
|
|
2008-04-23
|
5.341961325967
|
n-octadecyl-n-propyl-sulfamide
|
|
PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression |
5.341961325967
|
| 10006782 |
Oleic Acid-2,6-diisopropylanilide
|
|
140112-65-8 |
>98%
|
|
|
2005-05-18
|
1.986552486188
|
oleic-acid-2-6-diisopropylanilide
|
|
HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits low-density liproteins high-density inhibition atherosclerosis |
1.986552486188
|
| 10006529 |
Oleyl Anilide
|
|
5429-85-6 |
>95%
|
|
|
2005-05-18
|
2.062342541436
|
oleyl-anilide
|
OA; Oleic Acid Anilide
|
HDL LDL cholesterols ACAT inhibitors ODA acylCoA:cholesterol acyltransferase intracellular cholesteryl esters synthases dietary inhibits glycerides dioleoyl phenylamino propane 1,2-diols eosinophilia excessive T cell activation acute pulmonary inflammatory reactions TOS toxic oil syndrome aniline-denatured cooking oils interleukins atherosclerosis |
2.062342541436
|
| 10010374 |
p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit
|
|
- |
|
|
|
2007-09-17
|
2.067087608524
|
p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit
|
|
phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric |
2.067087608524
|
| 301707 |
PGC-1 Blocking Peptide
|
|
- |
|
|
|
2006-07-25
|
16.098563535912
|
pgc-1-blocking-peptide
|
|
antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases proteins peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity |
16.098563535912
|
| 101707 |
PGC-1 Polyclonal Antibody
|
|
- |
|
|
|
2005-10-12
|
29.541506780512
|
pgc-1-polyclonal-antibody
|
PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1
|
atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting |
29.541506780512
|
| 10011499 |
phytanoyl-Coenzyme A (triethylammonium salt)
Exclusive |
|
- |
≥95%
|
|
✓ |
2008-10-22
|
3.011588397790
|
phytanoyl-coenzyme-a-triethylammonium-salt
|
Phytanic Acid Coenzyme A Ester (triethylammonium salt); phytanoyl-CoA (triethylammonium salt)
|
phytanic acids a-oxidation alpha-oxidation .alpha.-oxidation metabolism fatty peroxisomes Refsums disease Refsum's α-oxidation |
3.011588397790
|
| 10006915 |
PPARα Transcription Factor Assay Kit
|
|
- |
|
|
|
2005-08-25
|
32.840877478063
|
ppar-transcription-factor-assay-kit
|
Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF |
32.840877478063
|
| 10008878 |
PPARα, δ, γ Complete Transcription Factor Assay Kit
|
|
- |
|
|
|
2006-08-22
|
50.811397000789
|
ppar-complete-transcription-factor-assay-kit
|
|
PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric |
50.811397000789
|
| 10007685 |
PPARγ FP-Based Ligand Screening Assay Kit - Green
|
|
- |
|
|
|
2009-07-16
|
42.257910597690
|
ppar-fp-based-ligand-screening-assay-kit-green
|
Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists |
42.257910597690
|
| 71000 |
PPARγ Ligand Pack
|
|
- |
>98%
|
|
|
|
64.870607734806
|
ppar-ligand-pack
|
Peroxisome Proliferator-activated Receptor γ Pack
|
ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs |
64.870607734806
|
| 101700 |
PPARγ Polyclonal Antibody
|
|
- |
|
|
|
|
13.619415943173
|
ppar-polyclonal-antibody
|
Peroxisome Proliferator-activated Receptor γ
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors |
13.619415943173
|
| 10006855 |
PPARγ Transcription Factor Assay Kit
|
|
- |
|
|
|
2005-08-25
|
58.305307550644
|
ppar-transcription-factor-assay-kit
|
Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF |
58.305307550644
|
| 10007451 |
PPARδ (human recombinant)
|
|
- |
≥95%
|
|
|
2005-07-29
|
11.494211172498
|
ppar-human-recombinant
|
PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 |
11.494211172498
|
| 10006914 |
PPARδ Transcription Factor Assay Kit
|
|
- |
|
|
|
2005-08-23
|
35.103345994475
|
ppar-transcription-factor-assay-kit
|
Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF |
35.103345994475
|
| 10009568 |
PPARδ Western Ready Control
|
|
- |
|
|
|
2007-02-02
|
5.079270718232
|
ppar-western-ready-control
|
NUC1; PPARβ; FAAR; Nuclear Hormone Receptor 1; Peroxisome Proliferative Activated Receptor δ
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity |
5.079270718232
|
| 514531 |
Prostaglandin E Metabolite EIA Kit
|
|
- |
|
|
|
|
367.839143646408
|
prostaglandin-e-metabolite-eia-kit
|
Prostaglandin E Metabolite ELISA Kit; PGEM EIA Kit; PGE Metabolite EIA Kit
|
solid plates kitrecommendation:pge2 bicyclo-PGE2 metabolites 13,14-dihydro-15-keto-PGE2 prostaglandins measures kits eias enzyme immunoassays ELISAs assays |
367.839143646408
|
| 10008594 |
PSN632408
Exclusive |
|
857652-30-3 |
>98%
|
|
✓ |
2006-08-01
|
84.541160220994
|
psn632408
|
|
GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry |
84.541160220994
|
| 700470 |
Pyruvate Assay Kit
|
|
- |
|
|
|
2010-11-03
|
119.316251576563
|
pyruvate-assay-kit
|
Pyruvic Acid Assay Kit
|
kits assays measures measurements acids cells cellular metabolic metabolism pathways glucose glucolysis oxygen dehydrogenases acetyl-CoA coenzymes A citric cycle Kreb's Krebs ATP adenosines triphosphates carbohydrates gluconeogenesis fatty acids dietary supplements weight loss exercise endurance antioxidants biochemical reactions lactate redox NAD+ NADH circulatory failures blood shock livers diseases congestive hearts failures diabetes mellitus thiamine deficiency disorders fluorescence-based fluorescent quantifying biological samples serum plasma urine saliva intracellular extracellular concentrations culture acetyls phosphates hydrogens peroxides H2O2 carbon dioxides CO2 ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufins |
119.316251576563
|
| 10006270 |
Renin Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2005-05-04
|
71.973945160630
|
renin-inhibitor-screening-assay-kit
|
|
Protease measurement assays aspartyl renal juxtaglomerular cells sodium depletion blood volume pressure .beta.-adrenergic stimulation angiotensinogens angiotensins I II converting ACE monomeric zinc metalloenzymes vascular endothelium messengers RAS vasoconstrictor peripheral hypertension receptors blockers fluorescence fluorescent fluorometric atherosclerosis endocrinology |
71.973945160630
|
| 9000484 |
Rimonabant
|
|
168273-06-1 |
≥98%
|
|
|
2009-06-17
|
70.164019337016
|
rimonabant
|
SR141716
|
SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic |
70.164019337016
|
| 10006415 |
Ro 48-8071
|
|
161582-11-2 |
>98%
|
|
|
2005-06-01
|
6.522028413575
|
ro-48-8071
|
|
monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis |
6.522028413575
|
| 10011190 |
SIRT1 (human recombinant)
|
|
- |
≥60%
|
|
|
2008-09-24
|
14.804068916183
|
sirt1-human-recombinant
|
Silent Information Regulator 2; Sirtuin 1; SIR2-like Protein 1; SIR2L1; NAD-dependent Deacetylase 1
|
SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 1 SIR2alpha sirtuin type 1 |
14.804068916183
|
| 10011566 |
SIRT3 Direct Fluorescent Screening Assay Kit
|
|
- |
|
|
|
2008-08-21
|
37.379274861878
|
sirt3-direct-fluorescent-screening-assay-kit
|
|
SIRT 3 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human mitochondrial proteins mitochondrias localization matrix-processing peptidase translocated nucleus cells cellular stress overexpression mice mouse murine caloric restriction up-regulates expression levels white brown adipose tissue BAT cold exposure PGC-1a PGC-1alpha PGC-1.alpha. UCP1 modulates adaptive thermogenesis deacetylation activation acetyl coenzymes A synthetase 2 AceCS2 catalyzes acetate CoA ketogenesis ATP direct genetic link longevity mutations genes enhancers marker life extension cellular metabolic control whole-body metabolism chronic diseases dysfunction neuronal pathogenesis neurodegenerative cancers aging apoptosis screening fluorescence activators fluorescent fluorometric |
37.379274861878
|
| 10011194 |
SIRT3 (human recombinant)
|
|
- |
≥90%
|
|
|
2008-12-15
|
17.771777727044
|
sirt3-human-recombinant
|
SIR2L3; Mitochondrial Nicotinamide Adenine Dinuclear-dependent Deacetylase; SIR2-like Protein 3; NAD-dependent Deacetylase 3; Silent Information Regulator 3; Sirtuin 3
|
SIRT 3 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 3 sirtuin type 3 sir2-like 3 |
17.771777727044
|
| 10317 |
SIRT4 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-01-06
|
4.168820297398
|
sirt4-human-recombinant
|
Sirtuin 4; Silent Information Regulator 4; SIR2L4; NAD-dependent ADP-ribosyltransferase Sirtuin 4; SIR2-like Protein 4
|
SIRTs Sirtuins HDACs proteins His-tagged hexahistidines HDACS histone decatylases GDH glutamate dehydrogenase sirtuin silent mating type information regulation 2 homolog 4 sirtuin type 4 |
4.168820297398
|
| 10315 |
SIRT6 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-07-31
|
11.980524861878
|
sirt6-human-recombinant
|
Sirtuin 6; NAD-dependent Deacetylase 6; Silent Information Regulator 6; SIR2L6; SIR2-like Protein 6
|
SIRTs Sirtuins HDACs proteins His-tagged hexahistidine silent mating type information regulation 2 homolog 6 sirtuin type 6 |
11.980524861878
|
| 10316 |
SIRT7 (human recombinant)
|
|
- |
≥85%
|
|
|
2009-12-22
|
9.669181681201
|
sirt7-human-recombinant
|
SIR2L7; Sirtuin 7; Silent Information Regulator 7; SIR2-like protein 7; NAD-dependent deacetylase 7
|
SIRTs Sirtuins HDACs proteins His-tagged hexahistidine histone deacetylases silent mating types information regulators 2 homologs |
9.669181681201
|
| 10010146 |
Soluble Epoxide Hydrolase Polyclonal Antibody
|
|
- |
|
|
|
2008-03-03
|
7.101390965226
|
soluble-epoxide-hydrolase-polyclonal-antibody
|
Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH)
|
metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting |
7.101390965226
|
| 10007663 |
SREBP-2 Polyclonal Antibody
|
|
- |
|
|
|
2006-02-22
|
74.042265193369
|
srebp-2-polyclonal-antibody
|
Sterol Regulatory Element-binding Transcription Factor 2; SREBF2; Sterol Regulatory Element-binding Protein-2
|
atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds proteins nucleus cells livers brown fats testis HepG2 human fibroblasts endocrinology immunoblotting |
74.042265193369
|
| 10026 |
T0070907
|
|
313516-66-4 |
>98%
|
|
|
|
65.236381215470
|
t0070907
|
|
T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology |
65.236381215470
|
| 10008517 |
Tienilic Acid
|
|
40180-04-9 |
>99%
|
|
|
2006-05-11
|
28.477697974217
|
tienilic-acid
|
|
substrates CYP450 CYP-450-2C9 CYP-2C9 CYP2C9 cytochromes M02001 CYP2C10 liver oxidation |
28.477697974217
|
| 10005263 |
TOFA
|
|
54857-86-2 |
>98%
|
|
|
2004-07-28
|
57.209779005525
|
tofa
|
RMI 14514; 5-(Tetradecyloxy)-2-Furoic Acid
|
inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology |
57.209779005525
|
| 10010303 |
Triglyceride Colorimetric Assay Kit
|
|
- |
|
|
|
2007-10-31
|
273.486091224874
|
triglyceride-colorimetric-assay-kit
|
|
assays kits triglycerides enzymes enzymatic hydrolysis water-insoluble lipids three fatty acids esterified glycerols blood serums lipoproteins chylomicrons very low density VLDLs dietary fats metabolisms energy diagnosis primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstruction endocrine colorimetric fluorometric plasmas coupled reaction systems |
273.486091224874
|
| 700730 |
Triglyceride Fluorometric Assay Kit
New |
|
- |
|
|
|
2012-01-17
|
126.316138735420
|
triglyceride-fluorometric-assay-kit
|
|
assays kits measures measurements flourometer fluorometry triglycerides water-insoluble lipids fatty acids esterified glycerols blood lipoproteins chylomicrons very low-density VLDLs dietary fats hydrolyzed hydrolysis free FFAs monoglycerides diglycerides intestines intestinal villi guts resynthesized capillary beds lipases adipose tissues storage stream oxidized mitrochondrias peroxisomes energy metabolisms levels lipids primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstructions endocrine disorders enzymatic hydrolysis fluorescence-based plasmas serums phosphorylated glycerol-3-phosphates G-3-P adenosine-5'-diphosphates ADP oxidized phosphates oxidases dihydroxyacetones hydrogen peroxides H2O2 horseradish HRPs 1-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin |
126.316138735420
|
| 71750 |
Troglitazone
|
|
97322-87-7 |
>98%
|
|
|
|
165.226773480663
|
troglitazone
|
ResulinTM
|
antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology |
165.226773480663
|
| 700620 |
Urea Fluorometric Assay Kit
New |
|
- |
|
|
|
2011-08-31
|
95.065620018036
|
urea-fluorometric-assay-kit
|
|
kits assays measures measurements carbamide cycle protein amino acids aa metabolisms catabolism deaminated ammonia livers N-acetylglutamate blood kidneys urine nitrogen countercurrent exchange systems nephrons kidneys creatinine prerenal hperuremia cardiac decompensation water depletion renal glomerulonephritis chronic nephritis polycystic nephrosclerosis tubular necrosis urinary tract toxic metabolites ammonium hyperammonemia plasma detoxification neurological brain neuroprotection serum urease hydrolysis carbon dioxide CO2 detector fluorescence fluorescent |
95.065620018036
|
| 10812 |
Vaspin (human) Monoclonal Antibody (Clone VP63)
|
|
- |
|
|
|
2011-06-27
|
4.667817679558
|
vaspin-human-monoclonal-antibody-clone-vp63
|
OL-64; Visceral Adipose Tissue-Derived Serine Protease Inhibitor; Serpin A12
|
antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay serpin adipocytokine immune response inflammation obesity insulin |
4.667817679558
|
| 70730 |
Wy 14643
|
|
50892-23-4 |
>98%
|
|
|
|
112.485773480663
|
wy-14643
|
Pirinixic Acid
|
activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 |
112.485773480663
|
| 71800 |
(Z)-Guggulsterone
|
|
39025-23-5 |
≥98%
|
|
|
2009-12-01
|
0.489963167587
|
-z-guggulsterone
|
|
anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt |
0.489963167587
|
| 700190 |
β-Hydroxybutyrate (Ketone Body) Assay Kit
|
|
- |
|
|
|
2009-06-02
|
157.381613542995
|
-hydroxybutyrate-ketone-body-assay-kit
|
β-HB Assay Kit; 3-Hydroxybutyric Acid Assay Kit
|
.beta.-hydroxybutyrate beta-hydroxybutyrate b-hydroxybutyrate b-HB beta-HB .beta.-HB β-HB 3-hydroxybutyric acids ketones body bodies acetoacetates acetones ketosis lipids metabolisms fasting exercise diets diabetes childhood hypoglycemia corticosteroids growth hormones deficiency intoxication alcohols salicylates organ failure ketoacidosis metabolic acidosis blood serums subclinical glucose diabetic coma hyperosmolar non-ketotic insulin hyperketonemia neurodegenerative diseases inhibits inhibition adipocytes lipolysis plasmas urine assays |
157.381613542995
|